-
Is Regeneron Pharmaceuticals Stock Underperforming the Nasdaq?
28 Feb 2026 12:04 GMT
… Inc. (REGN), is a biotechnology company headquartered in Tarrytown, New … within this group. The biotechnology leader is widely recognized … , compared to the broader Nasdaq Composite’s ($NASX) 2 … compared to its rival, Amgen Inc. (AMGN), which gained 26.9% …
-
AMGEN TO PRESENT AT THE 46TH ANNUAL TD COWEN HEALTH CARE CONFERENCE
25 Feb 2026 01:57 GMT
Amgen (NASDAQ:AMGN) will present at the 46th … days after the event.
About Amgen
Amgen discovers, develops, manufactures and delivers … 45 years ago, Amgen helped establish the biotechnology industry at its U …
-
Got $10,000? Put It in These Dividend Stocks Now
26 Feb 2026 15:28 GMT
… Transfer stock right now.
Amgen (AMGN)
I’m trying to … $2,500 investment is Amgen (NASDAQ:AMGN), a well-established pharmaceutical … to buy and hold a biotechnology stock? That’s understandable, … products provider, Cisco Systems (NASDAQ:CSCO).
The harsh truth …
-
Ligand Reports Fourth Quarter and Full Year 2025 Financial Results
26 Feb 2026 12:00 GMT
Robust financial performance driven by full year 2025 royalty revenue growth of 48% Reiterating 2026 financial guidance of $245-$285 million in revenues and adjusted earnings per diluted share1 of $8.00-$9.00 Conference call and webcast at 8:30 a.m. …
-
Protein Engineering Market to Reach US$ 8,646.10 Million by 2033 at 15.6% CAGR; North America Leads with 39% Share
27 Feb 2026 12:30 GMT
… with increasing investments in biotechnology research and development. The … Amgen, Inc. | Others
North America – 39% share: “Driven by strong biotechnology … driven by increasing investments in biotechnology, expanding pharmaceutical manufacturing, and …
-
Generate caps a strong month for biotech IPOs with $400M offering
27 Feb 2026 05:04 GMT
… offering to date for a biotechnology firm.
The company, which was … in payments from collaborations with Amgen and Novartis. Its main focus …
-
Physician-Scientist Reshma Kewalramani Runs One of Biotech’s Biggest Companies
26 Feb 2026 22:00 GMT
… drug research and development at Amgen, and her present role as … CEO of a large, public biotechnology company. Under her leadership, Vertex …
-
insitro Appoints Joe Hand as Chief People Officer to Advance Talent Strategy for Next Stage of Development
26 Feb 2026 14:31 GMT
… billion divestiture of Otezla to Amgen, the $9 billion acquisition of … NORTH AMERICA
INDUSTRY KEYWORD: SCIENCE BIOTECHNOLOGY RESEARCH HEALTH ARTIFICIAL INTELLIGENCE HEALTH …
-
REGENEXBIO Inc. v. Sarepta Therapeutics, Inc. (Fed. Cir. 2026)
25 Feb 2026 02:14 GMT
… , albeit a complex one” in Amgen Inc. v. Chugai Pharmaceutical Co … .
The opinion then assays other biotechnology-related patent eligibility decisions, particularly …
-
Esophageal Cancer Clinical Trial Pipeline Accelerates As 80+ Pharma Companies Rigorously Develop Drugs For Market Entry Delveinsight
25 Feb 2026 01:48 GMT
… , AstraZeneca, CSPC ZhongQi Pharmaceutical Technology, Amgen, Jiangsu Hengrui Medicine, Oncolys Biopharma … Pharmaceuticals, Merck KGaA, Shenzhen Hornetcorn Biotechnology, Apexigen, Inc., Highlight Therapeutics, EMD …
About
© 1995-2026